Structures by: Jayabharathi J.
Total: 33
C32H22N2O
C32H22N2O
New J. Chem. (2015) 39, 1 142
a=12.3316(7)Å b=21.3475(11)Å c=8.8212(5)Å
α=90.00° β=92.340(3)° γ=90.00°
C29H20N2
C29H20N2
RSC Adv. (2014) 4, 13 6790
a=15.2615(9)Å b=16.0717(7)Å c=16.9595(8)Å
α=90.00° β=90.00° γ=90.00°
1-(4-Methoxyphenyl)-2-[4-(trifluromethyl)phenyl]-1<i>H</i>-phenanthro[9,10-<i>d</i>]imidazole
C29H19F3N2O
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 8 o1293-4
a=11.7063(9)Å b=20.2301(16)Å c=9.5419(8)Å
α=90.00° β=99.725(2)° γ=90.00°
2-(4-Fluorophenyl)-1-(4-methoxyphenyl)-1<i>H</i>-phenanthro[9,10-<i>d</i>]imidazole
C28H19FN2O
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 3 o368
a=9.6430(3)Å b=9.8980(3)Å c=12.3070(4)Å
α=77.4320(10)° β=71.6210(10)° γ=73.1580(10)°
1-(3,5-Dimethylphenyl)-2-(4-fluorophenyl)-1<i>H</i>-phenanthro[9,10-<i>d</i>]imidazole
C29H21FN2
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 3 o367
a=8.5680(2)Å b=10.6070(3)Å c=23.6900(6)Å
α=90° β=93.8990(10)° γ=90°
1-Phenyl-2-[4-(trifluoromethyl)phenyl]-1<i>H</i>-benzimidazole
C20H13F3N2
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 2 o244
a=8.7179(4)Å b=9.6796(5)Å c=11.3612(6)Å
α=67.654(2)° β=68.123(2)° γ=85.013(2)°
Benzimidazole
C19H14N2O
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 1 o62
a=8.1941(6)Å b=9.5983(14)Å c=10.3193(18)Å
α=64.637(16)° β=80.356(10)° γ=83.610(9)°
2-(4-Methoxyphenyl)-1-phenyl-1<i>H</i>-benzimidazole
C20H16N2O
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 2 o269-70
a=12.3220(3)Å b=7.3030(2)Å c=18.2450(3)Å
α=90° β=108.9090(10)° γ=90°
Di-2-furylpiperidin-4-one
C20H19NO3
Acta Crystallographica Section E (2007) 63, 6 o2910-o2910
a=5.443(5)Å b=21.437(5)Å c=14.108(5)Å
α=90° β=91.037(5)° γ=90°
Diphenylpiperidin-4-ol
C19H23NO
Acta Crystallographica Section E (2007) 63, 6 o2886-o2886
a=11.6611(3)Å b=12.4948(4)Å c=12.0089(3)Å
α=90° β=117.3080(10)° γ=90°
Diphenylpiperidin-4-one
C19H21NO
Acta Crystallographica Section E (2007) 63, 8 o3504-o3504
a=7.1392(3)Å b=10.5811(5)Å c=11.6276(5)Å
α=102.320(2)° β=107.613(2)° γ=101.735(2)°
Piperidone
C25H23NO2
Acta Crystallographica Section E (2007) 63, 12 o4533-o4533
a=10.5355(3)Å b=9.3464(2)Å c=21.0493(5)Å
α=90° β=101.520(3)° γ=90°
Piperidine derivative
C20H15Cl2N3
Acta Crystallographica Section E (2007) 63, 12 o4853-o4853
a=15.1732(10)Å b=7.5493(5)Å c=16.3452(12)Å
α=90° β=105.494(7)° γ=90°
Piperidine derivative
C21H25NO2
Acta Crystallographica Section E (2007) 63, 12 o4826-o4826
a=14.4091(5)Å b=12.8347(4)Å c=10.1715(4)Å
α=90° β=99.584(4)° γ=90°
Piperidin-4-one
C15H17NO3
Acta Crystallographica Section E (2008) 64, 1 o59-o59
a=5.1620(2)Å b=20.2855(9)Å c=12.9825(5)Å
α=90° β=91.128(3)° γ=90°
Piperidin-4-one derivative
C26H27NO3
Acta Crystallographica Section E (2008) 64, 7 o1181
a=5.5612(2)Å b=13.8097(5)Å c=14.5119(6)Å
α=71.629(2)° β=79.928(2)° γ=82.526(2)°
Piperidin-4-one Oxime
C26H28N2O3
Acta Crystallographica Section E (2008) 64, 7 o1211
a=10.2472(4)Å b=11.2723(4)Å c=38.4188(15)Å
α=90° β=90° γ=90°
Piperidin-4-one
C22H27NO
Acta Crystallographica Section E (2009) 65, 12 o3083
a=12.2318(5)Å b=5.5879(2)Å c=26.9977(10)Å
α=90° β=94.377(3)° γ=90°
1H-imidazole
C25H16N4
Acta Crystallographica Section E (2011) 67, 4 o989
a=8.8693(7)Å b=10.0637(6)Å c=11.8960(9)Å
α=100.219(6)° β=110.310(7)° γ=102.475(6)°
1H-imidazole
C18H17FN2
Acta Crystallographica Section E (2010) 66, 7 o1703
a=9.8888(2)Å b=7.66930(10)Å c=20.1017(3)Å
α=90° β=95.9150(10)° γ=90°
1H-imidazole
C18H17FN2O
Acta Crystallographica Section E (2010) 66, 7 o1791
a=8.51320(10)Å b=9.5128(2)Å c=19.2610(3)Å
α=90° β=96.798(2)° γ=90°
1H-imidazole
C19H20N2,0.5(H2O)
Acta Crystallographica Section E (2010) 66, 11 o2776
a=16.7611(2)Å b=11.5467(2)Å c=16.6563(2)Å
α=90° β=90° γ=90°
1H-imidazole
C18H18N2
Acta Crystallographica Section E (2010) 66, 11 o2826
a=9.6971(3)Å b=7.5458(2)Å c=19.8407(7)Å
α=90° β=96.604(3)° γ=90°
1H-imidazole
C27H19FN2
Acta Crystallographica Section E (2010) 66, 10 o2519
a=10.1794(5)Å b=10.5239(6)Å c=10.6175(6)Å
α=80.750(5)° β=85.776(4)° γ=67.348(5)°
1H-imidazole
C17H16N2,H2O
Acta Crystallographica Section E (2010) 66, 9 o2219
a=25.5498(2)Å b=25.5498(2)Å c=9.37920(10)Å
α=90° β=90° γ=90°
1H-imidazole
C19H19FN2
Acta Crystallographica Section E (2011) 67, 5 o1065
a=8.4226(10)Å b=9.5572(10)Å c=11.0351(11)Å
α=105.423(9)° β=105.677(9)° γ=95.781(9)°
1-(3,5-Dimethoxyphenyl)-2-(4-fluorophenyl)-4,5-dimethyl-1<i>H</i>-imidazole
C19H19FN2O2
Acta Crystallographica Section E (2012) 68, 2 o256
a=6.96540(10)Å b=17.8520(3)Å c=13.7121(3)Å
α=90° β=97.833(2)° γ=90°
1H-imidazole
C25H15FN4,H2O
Acta Crystallographica Section E (2011) 67, 8 o1965
a=9.0103(10)Å b=10.0946(9)Å c=11.3994(9)Å
α=86.987(7)° β=75.950(8)° γ=82.396(8)°
Benzimidazole
C22H20N2
Acta Crystallographica Section E (2011) 67, 12 o3519
a=9.6610(2)Å b=10.2900(2)Å c=17.7271(3)Å
α=84.437(2)° β=81.536(2)° γ=76.165(2)°
Phenanthro[9,10-d]imidazole
C28H19FN2
Acta Crystallographica Section E (2012) 68, 10 o2880
a=10.1809(2)Å b=10.7654(2)Å c=18.4871(3)Å
α=90° β=96.1150(10)° γ=90°
Benzimidazole
C19H13FN2
Acta Crystallographica Section E (2012) 68, 9 o2708
a=8.7527(4)Å b=10.1342(4)Å c=17.0211(6)Å
α=90° β=104.187(4)° γ=90°
1H-benzimidazole
C19H14N2
Acta Crystallographica Section E (2012) 68, 12 o3283
a=10.1878(3)Å b=16.6399(4)Å c=17.4959(5)Å
α=90° β=106.205(3)° γ=90°
2-(4-(trifluoromethyl)phenyl)-1H-phenanthro[9,10-d]imidazole
C29H19F3N2
Acta Crystallographica Section E (2013) 69, 5 o710
a=8.113(3)Å b=11.733(5)Å c=12.713(2)Å
α=76.3970(10)° β=73.490(2)° γ=86.185(5)°